Systemic hemodynamic , neurohormonal , and renal effects of a steady - state infusion of human brain natriuretic peptide in <font color="red">patients_5</font> <font color="red">with_5</font> <font color="red">hemodynamically_5</font> <font color="red">decompensated_5</font> <font color="red">heart_5</font> <font color="red">failure_5</font> <font color="red">._5</font> <font color="red">
<br>
<br>_1</font> BACKGROUND Human brain natriuretic peptide ( hBNP ) is a promising agent for the treatment of decompensated cardiac failure . However , the systemic hemodynamic , neurohormonal , and renal effects of hBNP have been incompletely studied in <font color="red">human_1</font> <font color="red">heart_1</font> <font color="red">failure_1</font> <font color="red">._1</font> 
<br> METHODS AND RESULTS <font color="red">The_1</font> <font color="red">effects_1</font> <font color="red">of_1</font> <font color="red">a_1</font> <font color="red">continuous_1</font> <font color="red">4-hour_1</font> <font color="red">infusion_1</font> <font color="red">of_1</font> <font color="red">hBNP_1</font> <font color="red">were_1</font> <font color="red">determined_1</font> <font color="red">in_1</font> <font color="red">16_6</font> <font color="red">decompensated_6</font> <font color="red">heart_6</font> <font color="red">failure_6</font> <font color="red">patients_6</font> <font color="red">in_2</font> <font color="red">an_2</font> <font color="red">invasive_2</font> <font color="red">,_2</font> <font color="red">randomized_2</font> <font color="red">,_2</font> <font color="red">double_2</font> <font color="red">-_2</font> <font color="red">blind_2</font> <font color="red">,_2</font> <font color="red">placebo_2</font> <font color="red">-_2</font> <font color="red">controlled_2</font> <font color="red">study_2</font> <font color="red">._2</font> <font color="red">Patients_1</font> <font color="red">were_1</font> <font color="red">evaluated_1</font> <font color="red">during_1</font> <font color="red">three_1</font> <font color="red">4-hour_1</font> <font color="red">study_1</font> <font color="red">periods_1</font> <font color="red">:_1</font> <font color="red">baseline_1</font> <font color="red">,_1</font> <font color="red">treatment_1</font> <font color="red">(_1</font> <font color="red">placebo_1</font> <font color="red">[_1</font> <font color="red">n_1</font> <font color="red">=_1</font> <font color="red">4_1</font> <font color="red">]_1</font> <font color="red">versus_1</font> <font color="red">hBNP_1</font> <font color="red">0.025_1</font> <font color="red">or_1</font> <font color="red">0.05_1</font> <font color="red">microgram_1</font> <font color="red">/_1</font> <font color="red">kg_1</font> <font color="red">/_1</font> <font color="red">min_1</font> <font color="red">[_1</font> <font color="red">n_1</font> <font color="red">=_1</font> <font color="red">12_1</font> <font color="red">]_1</font> <font color="red">)_1</font> <font color="red">,_1</font> <font color="red">and_1</font> <font color="red">post_1</font> <font color="red">-_1</font> <font color="red">treatment_1</font> <font color="red">._1</font> <font color="red">Urinary_1</font> <font color="red">volume_1</font> <font color="red">losses_1</font> <font color="red">were_1</font> <font color="red">replaced_1</font> <font color="red">hourly_1</font> <font color="red">to_1</font> <font color="red">separate_1</font> <font color="red">the_1</font> <font color="red">vasodilatory_1</font> <font color="red">and_1</font> <font color="red">diuretic_1</font> <font color="red">effects_1</font> <font color="red">of_1</font> <font color="red">hBNP_1</font> <font color="red">._1</font> <font color="red">Two_1</font> <font color="red">patients_1</font> <font color="red">in_1</font> <font color="red">the_1</font> <font color="red">hBNP_1</font> <font color="red">group_1</font> <font color="red">were_1</font> <font color="red">excluded_1</font> <font color="red">from_1</font> <font color="red">the_1</font> <font color="red">analysis_1</font> <font color="red">because_1</font> <font color="red">of_1</font> <font color="red">adverse_1</font> <font color="red">events_1</font> <font color="red">._1</font> hBNP significantly ( P < .001 ) reduced right atrial pressure and pulmonary capillary wedge pressure by approximately 30% and 40% , respectively . hBNP also significantly lowered systemic vascular resistance from 1722 + /- 139 to 1101 + /- 83 dynes.s.cm-5 ( P < .05 ) . These unloading effects of hBNP produced a 28% increase in cardiac index ( P < .05 ) with no change in heart rate . Compared to placebo , hBNP decreased plasma norepinephrine and aldosterone . Renal hemodynamics were unaffected by hBNP ; however , most patients were resistant to its natriuretic effect . 
<br> CONCLUSIONS 1 ) The predominant hemodynamic effects of hBNP were a decrease in cardiac preload and systemic vascular resistance . 2 ) hBNP also improved cardiac output without increasing heart rate . 3 ) Plasma norepinephrine and aldosterone levels decreased during hBNP infusion . 4 ) hBNP is pharmacologically active and has potential in the therapy for decompensated heart failure .